{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T11:17:32Z","timestamp":1794223052812,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T00:00:00Z","timestamp":1674432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"ERC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021821","name":"Oncode Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021821","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["319661"],"award-info":[{"award-number":["319661"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["1334713-6"],"award-info":[{"award-number":["1334713-6"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.xcrm.2023.100941","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T11:08:58Z","timestamp":1676977738000},"page":"100941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["An adverse tumor-protective effect of IDO1 inhibition"],"prefix":"10.1016","volume":"4","author":[{"given":"Juliana C.N.","family":"Kenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Vredevoogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beaunelle","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joleen J.H.","family":"Traets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda","family":"Ib\u00e1\u00f1ez-Molero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan M.","family":"Schieven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Krijgsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuilman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pozniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabricio","family":"Loayza-Puch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Terry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike E.W.","family":"Logtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"de Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Ren\u00e9","family":"K\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Goding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuven","family":"Agami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1293-3177","authenticated-orcid":false,"given":"Daniel S.","family":"Peeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.100941_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1073\/pnas.78.1.129","article-title":"Induction of pulmonary indoleamine 2,3-dioxygenase by interferon","volume":"78","author":"Yoshida","year":"1981","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100941_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/bchm2.1936.243.6.237","article-title":"Studien \u00fcber den intermedi\u00e4ren Stoffwechsel des Tryptophans XVIII\u2014XXIV","volume":"243","author":"Kotake","year":"1936","journal-title":"Hoppe-Seyler's. Zeitschrift f\u00fcr. physiologische Chemie"},{"key":"10.1016\/j.xcrm.2023.100941_bib4","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nm934","article-title":"Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase","volume":"9","author":"Uyttenhove","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.100941_bib5","doi-asserted-by":"crossref","first-page":"531491","DOI":"10.3389\/fimmu.2020.531491","article-title":"Ido expression in cancer: different compartment, different functionality?","volume":"11","author":"Meireson","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.100941_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","article-title":"Inhibition of T\u00a0cell proliferation by macrophage tryptophan catabolism","volume":"189","author":"Munn","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.100941_bib7","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-14-0514","article-title":"Durable therapeutic efficacy utilizing combinatorial blockade against Ido, CTLA-4, and PD-L1 in mice with brain tumors","volume":"20","author":"Wainwright","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.100941_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-1426-2-3","article-title":"Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or Ido blockade involves restored IL-2 production and proliferation of CD8+ T\u00a0cells directly within the tumor microenvironment","volume":"2","author":"Spranger","year":"2014","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2023.100941_bib35","doi-asserted-by":"crossref","first-page":"30274","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2023.100941_bib9","article-title":"Companies scaling back Ido1 inhibitor trials","volume":"8","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.100941_bib10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.100941_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ijc.2910600117","article-title":"THE role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-\u03b3 in\u00a0vivo","volume":"60","author":"Burke","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2023.100941_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","article-title":"Mechanism of interferon-\u03b3 action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon -\u03b3 and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity","volume":"263","author":"Takikawa","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.100941_bib13","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1073\/pnas.85.4.1242","article-title":"Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon \u03b3","volume":"85","author":"Ozaki","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100941_bib14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2019.06.014","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"178","author":"Vredevoogd","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/hgtb.2014.004","article-title":"Manufacture of gene-modified human T-cells with a memory stem\/central memory phenotype","volume":"25","author":"Gomez-Eerland","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.xcrm.2023.100941_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.celrep.2016.05.064","article-title":"BRAFV600E kinase domain duplication identified in therapy-refractory melanoma patient-derived xenografts","volume":"16","author":"Kemper","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2023.100941_bib17","doi-asserted-by":"crossref","first-page":"1730538","DOI":"10.1080\/2162402X.2020.1730538","article-title":"Tumor endothelial cell up-regulation of Ido1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy","volume":"9","author":"Georganaki","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2023.100941_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021800","article-title":"Summarizes and visualizes long lists of gene ontology terms","volume":"6","author":"Supek","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2023.100941_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16982","article-title":"Tumour-specific proline vulnerability uncovered by differential ribosome codon reading","volume":"530","author":"Loayza-Puch","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100941_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","article-title":"Anti-tumour immunity induces aberrant peptide presentation in melanoma","volume":"590","author":"Bartok","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100941_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","article-title":"Regulated translation initiation controls stress-induced gene expression in mammalian cells","volume":"6","author":"Harding","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib21","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.xcrm.2023.100941_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1097-2765(00)00028-9","article-title":"Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain","volume":"6","author":"Dong","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib23","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/emboj.2010.81","article-title":"The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation","volume":"29","author":"Ye","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2023.100941_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1101\/gad.290940.116","article-title":"Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma","volume":"31","author":"Falletta","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.100941_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.100941_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.100941_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1158\/2159-8290.CD-13-0424","article-title":"A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors","volume":"4","author":"Konieczkowski","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.100941_bib28","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1038\/ncomms6712","article-title":"Low MITF\/AXL ratio predicts early resistance to multiple targeted drugs in melanoma","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.100941_bib29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/2159-8290.CD-13-1007","article-title":"The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNF","volume":"4","author":"Smith","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.100941_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1101\/gad.324657.119","article-title":"Mitf\u2014the first 25 years","volume":"33","author":"Goding","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.100941_bib47","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1158\/0008-5472.CAN-07-6627","article-title":"CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells","volume":"68","author":"Krige","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.100941_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib32","article-title":"A TCF4\/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma","author":"Pozniak","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2023.100941_bib33","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.100941_bib52","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00262-011-1172-6","article-title":"An immune-active tumor microenvironment favors clinical response to ipilimumab","volume":"61","author":"Ji","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2023.100941_bib34","first-page":"291","article-title":"Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-\u03b3","volume":"1","author":"Hoekstra","year":"2020","journal-title":"Nat. Can. (Que.)"},{"key":"10.1016\/j.xcrm.2023.100941_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting Ido pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.xcrm.2023.100941_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.200505059","article-title":"Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation","volume":"170","author":"Wellbrock","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2023.100941_bib39","first-page":"2098","article-title":"The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma","volume":"62","author":"Selzer","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.100941_bib40","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2023.100941_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1083\/jcb.200410115","article-title":"MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A","volume":"168","author":"Loercher","year":"2005","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2023.100941_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-148X.2009.00653.x","article-title":"Fifteen-year quest for microphthalmia-associated transcription factor target genes","volume":"23","author":"Cheli","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.xcrm.2023.100941_bib43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","article-title":"Cancer stem cells versus phenotype-switching in melanoma","volume":"23","author":"Hoek","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.xcrm.2023.100941_bib44","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1038\/s41467-020-17739-8","article-title":"Reversal of pre-existing NGFR-driven tumor and immune therapy resistance","volume":"11","author":"Boshuizen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.100941_bib45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.molcel.2020.05.031","article-title":"Rational cancer treatment combinations: an urgent clinical need","volume":"78","author":"Boshuizen","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2023.100941_bib51","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.100941_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100941_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq-A Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2023.100941_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s12859-018-2353-5","article-title":"XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data","volume":"19","author":"Kluin","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2023.100941_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nprot.2010.43","article-title":"Detection of Mycoplasma in cell cultures","volume":"5","author":"Young","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2023.100941_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.100941_bib53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:51:14Z","timestamp":1770828674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2666379123000332"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100941","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An adverse tumor-protective effect of IDO1 inhibition","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.100941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100941"}}